Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
Titel:
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
Auteur:
Schlumberger, M. Elisei, R. Müller, S. Schöffski, P. Brose, M. Shah, M. Licitra, L. Krajewska, J. Kreissl, M.C. Niederle, B. Cohen, E.E.W. Wirth, L. Ali, H. Clary, D.O. Yaron, Y. Mangeshkar, M. Ball, D. Nelkin, B. Sherman, S.